Guanyi Huang

Title: Guanyi Huang: Innovator in Pharmaceutical Compositions

Introduction

Guanyi Huang is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing methods to counteract the cardiotoxic effects of chemotherapy. With a total of 4 patents to his name, Huang's work is paving the way for safer cancer treatments.

Latest Patents

One of Huang's latest patents focuses on pharmaceutical compositions and methods for countering chemotherapy-induced cardiotoxicity. This disclosure provides innovative methods and compositions aimed at reducing or eliminating cardiotoxicity, especially that induced by cancer treatments. The methods often involve administering protective agents such as myricetin, tricetin, robinetin, ficetin, vitexin, quercetin, dihydrorobinetin, kaempferol, and others in conjunction with cancer drugs. These compositions may also include co-formulations of protective agents with anthracycline drugs, enhancing the safety and efficacy of cancer therapies.

Career Highlights

Throughout his career, Guanyi Huang has worked with various companies, including Auransa Inc. and Sct II LLC. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Huang has collaborated with notable colleagues such as Christopher G. Armstrong and Kevin J. Kim. These partnerships have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Guanyi Huang is a distinguished inventor whose work in pharmaceutical compositions is making a significant impact on cancer treatment safety. His innovative approaches to reducing chemotherapy-induced cardiotoxicity are vital for improving patient outcomes.